Supernus Pharmaceuticals' GAAP net income for 2021 was $53.424 million, down 2.4 times from $126.95 million in the previous year. Revenue increased 11.4% to $579.775 million from $520.397 million a year earlier.
Supernus Pharmaceuticals' GAAP net income for 2021 was $53.424 million, down 2.4 times from $126.95 million in the previous year. Revenue increased 11.4% to $579.775 million from $520.397 million a year earlier. 
ir.supernus.com
English (US) 